Choi_ Nikolai stock.adobe.com News Weight loss and diabetes medication GLP-1 agonists may interfere with cancer imaging, new study finds The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET/CT scans, new research presented at the 38th Annual Congress of the European Association of Nuclear Medicine (EANM'25) has revealed. GLP-1 receptor agonists are now widely prescribed for individuals with type 2 diabetes and weight loss, with a 700% increase in usage reported in the United States between 2019 and 2023
In the cardiovascular system, GLP-1R is known to exist not only on cardiomyocytes and endothelial cells, but also in the autonomic nervous system, Figure 3 suggests that GLP-1R may have direct and indirect effects on the heart and blood vessels
This makes perfect sense given niacinamide's ability to strengthen the skin barrier and provide hydration [5]
Hepp R, Hay YA, Aguado C, Lujan R, Dauphinot L, Potier MC, et al
Oils such as coconut, rosehip, and others are known for their brightening and antioxidant properties, which can reduce pigmentation over time and improve overall skin tone